EUVIMEDPoznaj EUVIMED
Open access · CC BY-NC-ND 4.0

CRISPR Base Editing Correction of TGFBI Mutations in Autosomal Dominant Corneal Dystrophies

Jue Chen, Connor W Davison, James Ellis, Bridget Blevins, William Presley, Mason T Myers, Dejuan Kong, Zhonggang Hou, Shahzad I Mian, Lev Prasov, Yan Zhang

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.2.60 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Jue Chen and 10 co-authors. Institution: Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, United States. Major MEDLINE topics: Corneal Dystrophies, Hereditary, Mutation, Extracellular Matrix Proteins, Genetic Therapy. Cited 2 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS, NIGMS NIH HHS.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Purpose

Lattice and granular corneal dystrophy comprise two common TGFBI-associated autosomal dominant corneal disorders. Existing therapies are only temporizing and carry significant morbidity. Here, we develop a novel therapeutic approach using an adenine base editor (ABE) to correct common TGFBI mutations.

Method

We generated two human corneal epithelial (HCE) cell models harboring a copy of the most common disease-causing TGBFI mutations, R124C or R555W. These lines were electroporated with an ABE8e-NG-encoding mRNA and guide RNAs targeting the mutations. The resulting A•T-to-G•C editing efficiencies and off-target (OT) effects were assessed by amplicon sequencing. GFP-expressing adeno-associated viruses (AAVs) with different capsid types were transduced into HCE cells and healthy human corneal donor tissues, and GFP fluorescence was evaluated.

Results

Using all-RNA delivery for ABE8e-NG, we achieved 91% and 62% correction of the pathogenic adenines in HCE TGFBIR124C/WT and TGFBIR555W/WT cells, without editing the wild-type allele. Indel formation was negligible (

Subjects

MeSH terms (MEDLINE)

Corneal Dystrophies, HereditaryMutationExtracellular Matrix ProteinsGenetic TherapyTransforming Growth Factor betaGene EditingHumansbetaIG-H3 ProteinEpithelium, CornealCells, CulturedDependovirus

Substances

Extracellular Matrix ProteinsTransforming Growth Factor betabetaIG-H3 Protein

Authors and institutions

  • Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, United States.
  • Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States.
  • Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, United States.
  • Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States.

Funding

  • NEI NIH HHS
  • NIGMS NIH HHS

Cite

APA

Chen, J., Davison, C. W., Ellis, J., Blevins, B., Presley, W., Myers, M. T., Kong, D., Hou, Z., Mian, S. I., Prasov, L., & Zhang, Y. (2026). CRISPR Base Editing Correction of TGFBI Mutations in Autosomal Dominant Corneal Dystrophies. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.2.60

Vancouver

Chen J, Davison CW, Ellis J, Blevins B, Presley W, Myers MT, et al. CRISPR Base Editing Correction of TGFBI Mutations in Autosomal Dominant Corneal Dystrophies. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.2.60

BibTeX
@article{Chen2026,
  author = {Chen, Jue and Davison, Connor W and Ellis, James and Blevins, Bridget and Presley, William and Myers, Mason T and Kong, Dejuan and Hou, Zhonggang and Mian, Shahzad I and Prasov, Lev and Zhang, Yan},
  title = {CRISPR Base Editing Correction of TGFBI Mutations in Autosomal Dominant Corneal Dystrophies},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.2.60}
}
Start for free →